Exploring the interoceptive stimulus effects of nicotine and varenicline.

Brady M Thompson, Scott T Barrett, Rick A Bevins
Author Information
  1. Brady M Thompson: Department of Psychology, University of Nebraska-Lincoln, Lincoln, NE, USA.
  2. Scott T Barrett: Department of Psychology, University of Nebraska-Lincoln, Lincoln, NE, USA.
  3. Rick A Bevins: Department of Psychology, University of Nebraska-Lincoln, Lincoln, NE, USA. Electronic address: rbevins1@unl.edu.

Abstract

Learning processes associated with nicotine influence the development of addiction to tobacco products. In the present report, we are interested in the interoceptive stimulus effects of nicotine acquiring control over appetitive behaviors - specifically, reward seeking. Also of interest is the current smoking cessation drug, varenicline (Chantix®). Varenicline, with its nicotine-like stimulus effects, can decrease withdrawal and cravings for a subset of individuals addicted to nicotine, though relapse is still common. We trained rats (N = 48) with nicotine (0.4 mg/kg, SC) as an excitatory stimulus (i.e., paired with sucrose) in a drug-discriminated goal-tracking (DGT) task. There was no access to sucrose on interspersed saline days. After acquisition of the initial nicotine-saline discrimination, rats were separated into four groups to test discrimination reversal and drug substitution. The control group maintained nicotine as the excitatory stimulus (NIC+). The substitution group had varenicline (1 mg/kg) replace nicotine as the stimulus paired with sucrose (VAR+). One reversal group had nicotine signal the absence of sucrose (i.e., now available on intermixed saline sessions; NIC-). The last group was similar to the NIC- group except varenicline replaced nicotine on non-reinforced sessions (VAR-). We found that varenicline fully substituted as the training stimulus when the drug-sucrose relation remained in place (VAR+). Both reversal groups acquired the new discrimination, albeit slowly and more variable for the VAR- group in comparison to NIC-. There was an effect of group during substitution testing. Specifically, nicotine fully substituted for varenicline regardless of condition. However, varenicline only partially substituted for the nicotine stimulus. At the start of extinction, responding mimicked that of the rats training condition. However, by extinction session 12, all groups maintained similarly low levels of responding. These findings show nicotine and varenicline share stimulus elements, yet the conclusion of partial to full substitution depends on the nature of the testing protocol.

Keywords

References

  1. J Neurosci. 2008 Oct 22;28(43):10972-82 [PMID: 18945905]
  2. Cochrane Database Syst Rev. 2013 May 31;(5):CD009329 [PMID: 23728690]
  3. J Pharmacol Exp Ther. 2011 Oct;339(1):194-202 [PMID: 21730011]
  4. J Neurosci. 2003 Sep 24;23(25):8771-80 [PMID: 14507977]
  5. Pharmacol Biochem Behav. 2001 Jan;68(1):135-45 [PMID: 11274718]
  6. Behav Brain Res. 2007 Feb 12;177(1):134-41 [PMID: 17129619]
  7. Behav Processes. 2008 May;78(1):17-24 [PMID: 18191503]
  8. Psychopharmacology (Berl). 2014 Feb;231(4):765-75 [PMID: 24114425]
  9. J Gen Psychol. 2013 Jul-Sep;140(3):187-203 [PMID: 24837654]
  10. Behav Processes. 2012 May;90(1):28-33 [PMID: 22119845]
  11. ACS Chem Neurosci. 2014 Aug 20;5(8):624-31 [PMID: 25010473]
  12. Annu Rev Neurosci. 2011;34:105-30 [PMID: 21438686]
  13. Neuropsychopharmacology. 2012 Mar;37(4):876-84 [PMID: 22048468]
  14. Nicotine Tob Res. 2012 Mar;14(3):299-305 [PMID: 21994342]
  15. Psychopharmacology (Berl). 2015 Dec;232(23):4347-58 [PMID: 26364957]
  16. Neurobiol Learn Mem. 2014 Feb;108:22-7 [PMID: 23770491]
  17. Curr Drug Abuse Rev. 2009 Sep;2(3):243-55 [PMID: 20443771]
  18. Behav Pharmacol. 2018 Sep;29(6):493-502 [PMID: 29634495]
  19. Neuropharmacology. 2017 Feb;113(Pt A):354-366 [PMID: 27765626]
  20. Pharmacol Biochem Behav. 2009 Jan;91(3):461-7 [PMID: 18817808]
  21. J Med Chem. 2005 May 19;48(10):3474-7 [PMID: 15887955]
  22. Nat Neurosci. 2005 May;8(5):555-60 [PMID: 15856062]
  23. Neuropharmacology. 2016 Aug;107:100-110 [PMID: 27012889]
  24. Clin Pharmacokinet. 2010 Dec;49(12):799-816 [PMID: 21053991]
  25. J Mol Neurosci. 2006;30(1-2):133-5 [PMID: 17192659]
  26. Mol Neurobiol. 2008 Aug;38(1):101-21 [PMID: 18690555]
  27. Neuropsychopharmacology. 2005 Apr;30(4):731-41 [PMID: 15592350]
  28. Psychopharmacology (Berl). 2004 Feb;172(1):108-17 [PMID: 14530902]
  29. Neuroscience. 2017 Mar 14;345:130-141 [PMID: 27641830]
  30. Am J Health Syst Pharm. 2007 Jul 1;64(13):1381-4 [PMID: 17592002]
  31. Neuropharmacology. 2010 Jun;58(8):1237-45 [PMID: 20302882]
  32. Psychopharmacology (Berl). 2007 Feb;190(2):157-70 [PMID: 17115136]
  33. Nicotine Tob Res. 2016 Sep;18(9):1830-6 [PMID: 27013335]
  34. Neuroscience. 2017 Mar 14;345:27-37 [PMID: 26996511]
  35. Learn Mem. 2011 Jun 21;18(7):452-8 [PMID: 21693633]
  36. Behav Pharmacol. 2013 Feb;24(1):45-54 [PMID: 23263484]
  37. Mol Pharmacol. 2003 Dec;64(6):1283-94 [PMID: 14645658]
  38. Neuropsychologia. 2008 Aug;46(10):2476-84 [PMID: 18514746]
  39. J Exp Anal Behav. 1968 Mar;11(2):199-206 [PMID: 5645880]

Grants

  1. R01 DA034389/NIDA NIH HHS

MeSH Term

Animals
Appetitive Behavior
Conditioning, Classical
Discrimination Learning
Discrimination, Psychological
Drug Substitution
Extinction, Psychological
Injections, Subcutaneous
Interoception
Male
Nicotine
Nicotinic Agonists
Rats
Rats, Sprague-Dawley
Saline Solution
Smoking Cessation
Substance Withdrawal Syndrome
Sucrose
Varenicline

Chemicals

Nicotinic Agonists
Saline Solution
Sucrose
Nicotine
Varenicline

Word Cloud

Created with Highcharts 10.0.0nicotinestimulusvareniclinegroupsucrosediscriminationsubstitutioneffectsratsgroupsreversalNIC-substitutedinteroceptivecontroldrugChantix®VareniclineexcitatoryiepairedsalinemaintainedVAR+sessionsVAR-fullytrainingtestingconditionHoweverextinctionrespondingLearningprocessesassociatedinfluencedevelopmentaddictiontobaccoproductspresentreportinterestedacquiringappetitivebehaviors-specificallyrewardseekingAlsointerestcurrentsmokingcessationnicotine-likecandecreasewithdrawalcravingssubsetindividualsaddictedthoughrelapsestillcommontrainedN = 4804 mg/kgSCdrug-discriminatedgoal-trackingDGTtaskaccessintersperseddaysacquisitioninitialnicotine-salineseparatedfourtestNIC+1 mg/kgreplaceOnesignalabsencenowavailableintermixedlastsimilarexceptreplacednon-reinforcedfounddrug-sucroserelationremainedplaceacquirednewalbeitslowlyvariablecomparisoneffectSpecificallyregardlesspartiallystartmimickedsession12similarlylowlevelsfindingsshowshareelementsyetconclusionpartialfulldependsnatureprotocolExploringDrugNicotinePavlovianconditioningReversallearning

Similar Articles

Cited By